Healthcare provider profile · identity verified

James J Tess, M.D.

General Practice · ORLAND PARK, IL · NPI 1629016803

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	379	108
Atorvastatin Calcium	Atorvastatin Calcium	362	102
Levothyroxine Sodium	Levothyroxine Sodium	317	84
Amlodipine Besylate	Amlodipine Besylate	303	89
Pantoprazole Sodium	Pantoprazole Sodium	266	87
Metformin Hcl	Metformin Hcl	215	58
Alprazolam	Alprazolam	207	59
Losartan Potassium	Losartan Potassium	192	56
Pravastatin Sodium	Pravastatin Sodium	192	57
Glimepiride	Glimepiride	180	49
Ezetimibe	Ezetimibe	159	53
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	155	118
Simvastatin	Simvastatin	147	40
Omeprazole	Omeprazole	146	38
Sertraline Hcl	Sertraline Hcl	140	35
Metoprolol Succinate	Metoprolol Succinate	134	40
Hydrochlorothiazide	Hydrochlorothiazide	132	30
Montelukast Sodium	Montelukast Sodium	124	35
Tamsulosin Hcl	Tamsulosin Hcl	122	37
Zolpidem Tartrate	Zolpidem Tartrate	115	28
Escitalopram Oxalate	Escitalopram Oxalate	113	34
Olmesartan Medoxomil	Olmesartan Medoxomil	112	30
Lisinopril	Lisinopril	111	36
Metoprolol Tartrate	Metoprolol Tartrate	101	28
Methylprednisolone	Methylprednisolone	98	75
Allopurinol	Allopurinol	97	33
Fluoxetine Hcl	Fluoxetine Hcl	92	28
Furosemide	Furosemide	82	32
Jardiance	Empagliflozin	75	17
Synthroid	Levothyroxine Sodium	75	21
Candesartan Cilexetil	Candesartan Cilexetil	72	22
Azithromycin	Azithromycin	67	58
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	66	17
Bisoprolol Fumarate	Bisoprolol Fumarate	64	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	64	46
Prednisone	Prednisone	63	34
Meloxicam	Meloxicam	62	23
Gabapentin	Gabapentin	59	22
Benazepril Hcl	Benazepril Hcl	56	14
Eliquis	Apixaban	54	14
Nifedipine Er	Nifedipine	54	15
Albuterol Sulfate Hfa	Albuterol Sulfate	53	37
Duloxetine Hcl	Duloxetine Hcl	50	13
Doxycycline Monohydrate	Doxycycline Monohydrate	47	36
Tizanidine Hcl	Tizanidine Hcl	46	28
Potassium Chloride	Potassium Chloride	45	12
Tramadol Hcl	Tramadol Hcl	45	15
Fluticasone Propionate	Fluticasone Propionate	44	18
Clopidogrel	Clopidogrel Bisulfate	43	11
Metformin Hcl Er	Metformin Hcl	43	12
Pioglitazone Hcl	Pioglitazone Hcl	43	13
Carvedilol	Carvedilol	42	16
Diclofenac Sodium	Diclofenac Sodium	41	15
Hydralazine Hcl	Hydralazine Hcl	41	12
Lorazepam	Lorazepam	40	11
Donepezil Hcl	Donepezil Hcl	39	13
Fenofibrate	Fenofibrate Nanocrystallized	39	11
Ozempic	Semaglutide	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	15
Trazodone Hcl	Trazodone Hcl	37	suppressed
Finasteride	Finasteride	35	suppressed
Lovastatin	Lovastatin	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Irbesartan	Irbesartan	30	suppressed
Clonazepam	Clonazepam	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Cephalexin	Cephalexin	24	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Nystatin	Nystatin	23	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Atenolol	Atenolol	21	suppressed
Clindamycin Hcl	Clindamycin Hcl	21	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	13
Alendronate Sodium	Alendronate Sodium	19	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Dexamethasone	Dexamethasone	19	17
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	17	suppressed
Diazepam	Diazepam	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	11
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Glipizide	Glipizide	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Risperidone	Risperidone	12	suppressed
Topiramate	Topiramate	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sucralfate	Sucralfate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error